Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
Herold N, Schmolling J, Ernst C, Ataseven B, Blümcke B, Schömig-Markiefka B, Heikaus S, Göhring U-J, Engel C, Lampe B, Rhiem K, et al. (2023)
Cancer Medicine .
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Herold, Natalie;
Schmolling, Johanna;
Ernst, Corinna;
Ataseven, BeyhanUniBi;
Blümcke, Britta;
Schömig-Markiefka, Birgid;
Heikaus, Sebastian;
Göhring, Uwe-Jochen;
Engel, Christoph;
Lampe, Bjoern;
Rhiem, Kerstin;
Harter, Philipp
Alle
Alle
Einrichtung
Abstract / Bemerkung
To assess the role of germline pathogenic variants (PVs) in SMARCA4 and further established ovarian cancer (OC) predisposition genes in early onset OC, we investigated a clinical cohort of 206 unrelated OC index patients with an age at diagnosis of OC & LE;40 years using an extended panel of 24 (candidate) cancer predisposition genes. PVs in established OC predisposition genes were most frequent in patients with high grade serous OC (21/62, 33.9%), comparatively rare in patients with epithelial OC other than high grade serous (5/74, 6.8%) or borderline ovarian tumours (2/39, 5.1%) and absent in mucinous OC (0/27). We demonstrate that germline PVs in SMARCA4 unlikely predispose for early onset OC other than SCCOHT.
Stichworte
BRCA mutations;
cancer risk factors;
gynecological oncology;
hereditary;
cancer;
ovarian cancer;
SCCOHT;
SMARCA4
Erscheinungsjahr
2023
Zeitschriftentitel
Cancer Medicine
eISSN
2045-7634
Page URI
https://pub.uni-bielefeld.de/record/2980959
Zitieren
Herold N, Schmolling J, Ernst C, et al. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . 2023.
Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., et al. (2023). Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . https://doi.org/10.1002/cam4.6214
Herold, Natalie, Schmolling, Johanna, Ernst, Corinna, Ataseven, Beyhan, Blümcke, Britta, Schömig-Markiefka, Birgid, Heikaus, Sebastian, et al. 2023. “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”. Cancer Medicine .
Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., Göhring, U. - J., Engel, C., Lampe, B., et al. (2023). Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine .
Herold, N., et al., 2023. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine .
N. Herold, et al., “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”, Cancer Medicine , 2023.
Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., Göhring, U.-J., Engel, C., Lampe, B., Rhiem, K., Harter, P., Hauke, J., Schmutzler, R.K., Hahnen, E.: Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . (2023).
Herold, Natalie, Schmolling, Johanna, Ernst, Corinna, Ataseven, Beyhan, Blümcke, Britta, Schömig-Markiefka, Birgid, Heikaus, Sebastian, Göhring, Uwe-Jochen, Engel, Christoph, Lampe, Bjoern, Rhiem, Kerstin, Harter, Philipp, Hauke, Jan, Schmutzler, Rita K., and Hahnen, Eric. “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”. Cancer Medicine (2023).
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 37345881
PubMed | Europe PMC
Suchen in
Google Scholar